Stock PDEX PRO-DEX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Pro-Dex, Inc.

Equities

PDEX

US74265M2052

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
19.33 USD +2.22% Intraday chart for Pro-Dex, Inc. +7.99% +10.33%
05-02 Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $14.3M MT
05-02 Earnings Flash (PDEX) PRO-DEX Posts Q3 EPS $0.19 MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • With a 2024 P/E ratio at 38.66 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PRO-DEX, INC. Stock Pro-Dex, Inc.
+10.33% 66.4M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.51% 182B
C+
MEDTRONIC PLC Stock Medtronic plc
+2.33% 111B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.62% 68.48B
A
DEXCOM, INC. Stock DexCom, Inc.
+1.52% 49.69B
B-
CENCORA, INC. Stock Cencora, Inc.
+8.06% 44.46B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.38% 40.67B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+23.35% 31.22B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.67% 26.09B
A-
TERUMO CORPORATION Stock Terumo Corporation
+18.48% 25.32B
A-
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PDEX Stock
  4. Ratings Pro-Dex, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW